Most Recent
Mayne wins breathing room in fight to get Cosette merger over the line
Mayne Pharma has secured an extension of the deadline for securing Foreign Investment Review Board approval of its $672 million tie-up with US drug maker Cosette.
Cosette appeals loss over exit from $672M Mayne Pharma merger
Cosette plans to appeal a ruling that rejected its bid to terminate an agreement to merge with Mayne Pharma, as the US drug company also refuses to agree to conditions needed to win Foreign Investment Review Board approval for the tie-up.
Judge questions AMP class action’s bid to ‘prettify’ case on eve of trial
The applicant in a class action against AMP wants to amend the case five years in and three months out from trial, but a judge has warned he will look dimly on any changes that disrupt the evidence planned for the hearing.
Mayne Pharma wins suit over Cosette’s termination of $672M takeover
Mayne Pharma has won a dispute with US drug maker Cosette over the termination of a $672 million merger agreement, with a judge finding Mayne did not breach its continuous disclosure obligations by failing to disclose a letter from the US FDA sooner.
Construction PRO
Catalyst wins $32M from Presbyterian Church of Qld for failed land deals
Property group Catalyst has won $31.7 million from a trustee corporation of the Presbyterian Church of Queensland over a suite of scuppered transactions for land and aged care homes.
BlueScope loses appeal in ACCC’s attempted price-fixing case
An appeals court has dismissed BlueScope Steel's challenge to a decision finding it engaged in attempted price-fixing and was on the hook for a record $57.5 million penalty.
Uber did not conspire to take out TaxiApps, court says
TaxiApps, the operator of the GoCatch rideshare app, has failed to prove that Uber engaged in an unlawful conspiracy, despite a judge finding the rideshare giant intended to harm the defunct taxi app and "surreptitiously" obtained a confidential driver list. 
Trial over Cosette’s termination of $672M Mayne Pharma merger delayed
Mayne Pharma and US drug maker Cosette have agreed to postpone the start of trial in a case over the termination of a $672 million merger to allow for late amendments.
High Court shoots down solicitors’ CFO in Blue Sky class action
The High Court has unanimously found the Federal Court has no power to allow solicitors to take a cut of a settlement or judgment in a shareholder class action against Blue Sky, saying it would be contrary to rules against contingency fees in NSW. 
Qantas class action over flight credits blasts airline’s ‘wholly inadequate’ discovery
A class action against Qantas has characterised the airline’s document discovery as “wholly inadequate” and is resisting a bid by the airline for six more months to produce senior management emails.